Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eggton Plus is a multi-ingredient nutraceutical product developed by Biotics Lab, specifically formulated for joint protection and the management of arthritis symptoms. The primary active components are Natural Eggshell Membrane (NEM) and Boswellia serrata extract (often standardized as Aflapin). NEM is a naturally occurring source of glycosaminoglycans and proteins, including chondroitin sulfate, hyaluronic acid, and collagen, which are essential for maintaining the structural integrity of joint cartilage and reducing stiffness. Boswellia serrata provides potent anti-inflammatory activity by selectively inhibiting the 5-lipoxygenase (5-LOX) enzyme, thereby blocking the synthesis of pro-inflammatory leukotrienes. This synergistic combination aims to reduce joint pain, improve physical function, and slow the progression of joint degradation in conditions such as osteoarthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eggton Plus.